Morgan Stanley’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.9M | Buy |
2,571,723
+383,245
| +18% | +$3.56M | ﹤0.01% | 2623 |
|
2025
Q1 | $16M | Buy |
2,188,478
+365,553
| +20% | +$2.68M | ﹤0.01% | 2916 |
|
2024
Q4 | $15.6M | Buy |
1,822,925
+238,750
| +15% | +$2.04M | ﹤0.01% | 3001 |
|
2024
Q3 | $13.8M | Buy |
1,584,175
+421,694
| +36% | +$3.67M | ﹤0.01% | 3161 |
|
2024
Q2 | $7.95M | Sell |
1,162,481
-210,554
| -15% | -$1.44M | ﹤0.01% | 3495 |
|
2024
Q1 | $12.5M | Buy |
1,373,035
+726,725
| +112% | +$6.61M | ﹤0.01% | 3163 |
|
2023
Q4 | $2.88M | Buy |
646,310
+399,885
| +162% | +$1.78M | ﹤0.01% | 4735 |
|
2023
Q3 | $774K | Buy |
246,425
+13,660
| +6% | +$42.9K | ﹤0.01% | 4945 |
|
2023
Q2 | $1.2M | Sell |
232,765
-948,938
| -80% | -$4.9M | ﹤0.01% | 4728 |
|
2023
Q1 | $6.23M | Buy |
1,181,703
+753,831
| +176% | +$3.97M | ﹤0.01% | 3591 |
|
2022
Q4 | $1.2M | Buy |
427,872
+239,559
| +127% | +$673K | ﹤0.01% | 4759 |
|
2022
Q3 | $782K | Sell |
188,313
-40,828
| -18% | -$170K | ﹤0.01% | 5029 |
|
2022
Q2 | $920K | Buy |
229,141
+7,480
| +3% | +$30K | ﹤0.01% | 5065 |
|
2022
Q1 | $1.1M | Sell |
221,661
-200,711
| -48% | -$993K | ﹤0.01% | 4927 |
|
2021
Q4 | $2.94M | Sell |
422,372
-226,443
| -35% | -$1.58M | ﹤0.01% | 4259 |
|
2021
Q3 | $6.49M | Buy |
648,815
+156,948
| +32% | +$1.57M | ﹤0.01% | 3404 |
|
2021
Q2 | $6.97M | Buy |
491,867
+157,541
| +47% | +$2.23M | ﹤0.01% | 3418 |
|
2021
Q1 | $5.49M | Buy |
334,326
+72,409
| +28% | +$1.19M | ﹤0.01% | 3308 |
|
2020
Q4 | $5.42M | Sell |
261,917
-2,710
| -1% | -$56.1K | ﹤0.01% | 3175 |
|
2020
Q3 | $2.01M | Buy |
264,627
+68,514
| +35% | +$521K | ﹤0.01% | 3653 |
|
2020
Q2 | $1.63M | Buy |
196,113
+45,981
| +31% | +$383K | ﹤0.01% | 3786 |
|
2020
Q1 | $743K | Sell |
150,132
-88,589
| -37% | -$438K | ﹤0.01% | 4147 |
|
2019
Q4 | $943K | Buy |
238,721
+50,335
| +27% | +$199K | ﹤0.01% | 4577 |
|
2019
Q3 | $573K | Buy |
188,386
+11,922
| +7% | +$36.3K | ﹤0.01% | 4618 |
|
2019
Q2 | $777K | Sell |
176,464
-54,153
| -23% | -$238K | ﹤0.01% | 4366 |
|
2019
Q1 | $916K | Sell |
230,617
-93,663
| -29% | -$372K | ﹤0.01% | 4171 |
|
2018
Q4 | $1.29M | Buy |
324,280
+69,315
| +27% | +$276K | ﹤0.01% | 4093 |
|
2018
Q3 | $1.75M | Sell |
254,965
-22,831
| -8% | -$157K | ﹤0.01% | 4107 |
|
2018
Q2 | $1.88M | Buy |
277,796
+5,641
| +2% | +$38.1K | ﹤0.01% | 4137 |
|
2018
Q1 | $1.77M | Buy |
272,155
+13,230
| +5% | +$86.1K | ﹤0.01% | 4116 |
|
2017
Q4 | $1.15M | Sell |
258,925
-11,363
| -4% | -$50.6K | ﹤0.01% | 4443 |
|
2017
Q3 | $1.67M | Sell |
270,288
-128,782
| -32% | -$796K | ﹤0.01% | 4041 |
|
2017
Q2 | $3.7M | Sell |
399,070
-205,566
| -34% | -$1.91M | ﹤0.01% | 3202 |
|
2017
Q1 | $5.61M | Buy |
604,636
+275,950
| +84% | +$2.56M | ﹤0.01% | 2749 |
|
2016
Q4 | $2.75M | Sell |
328,686
-244,623
| -43% | -$2.05M | ﹤0.01% | 3626 |
|
2016
Q3 | $3.94M | Buy |
573,309
+474,703
| +481% | +$3.26M | ﹤0.01% | 2900 |
|
2016
Q2 | $488K | Buy |
98,606
+75,784
| +332% | +$375K | ﹤0.01% | 4437 |
|
2016
Q1 | $220K | Buy |
22,822
+16,572
| +265% | +$160K | ﹤0.01% | 4917 |
|
2015
Q4 | $59K | Sell |
6,250
-738
| -11% | -$6.97K | ﹤0.01% | 5643 |
|
2015
Q3 | $98K | Sell |
6,988
-10,616
| -60% | -$149K | ﹤0.01% | 5429 |
|
2015
Q2 | $370K | Sell |
17,604
-1,038
| -6% | -$21.8K | ﹤0.01% | 4914 |
|
2015
Q1 | $783K | Buy |
18,642
+3,294
| +21% | +$138K | ﹤0.01% | 4318 |
|
2014
Q4 | $361K | Sell |
15,348
-50,836
| -77% | -$1.2M | ﹤0.01% | 4897 |
|
2014
Q3 | $992K | Buy |
+66,184
| New | +$992K | ﹤0.01% | 4034 |
|